AMPH

Amphastar Pharmaceuticals, Inc.

40.15 USD
-0.39 (-0.96%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amphastar Pharmaceuticals, Inc. stock is down -6.78% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 10 June’s closed higher than May. 0% of analysts rate it a buy.

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs.